This shows the ongoing value of low level laser therapy in the aesthetic field and continues to establish how successful non-invasive body contouring products, such as ZERONA, have become in the last few years.
Dallas, TX (PRWEB) October 18, 2011
Santa Barbara Medical Innovations (SBMI) announced today that world-renowned dermatologist and laser surgeon, Dr. Mark S. Nestor, presented at the second 5-Continent Congress (5CC) last month in Cannes, France.
The 5CC was organized by an international group of dermatologists and plastic surgeons. This meeting is a professional three day conference dedicated to innovations and controversies in the field of aesthetic medicine.
Currently, Dr. Mark Nestor serves as Director of the Center for Cosmetic Enhancement and Director of the Center for Clinical and Cosmetic Research in Aventura, Florida. He is recognized as a world expert in laser surgery, and provides an array of research on ZERONA, the non-invasive body contouring device.
“We are pleased with Dr. Nestor’s presentation on the innovations in aesthetic procedures last month,” said Michael Browning, senior vice president of marketing and business development of SBMI. “This shows the ongoing value of low level laser therapy in the aesthetic field and continues to establish how successful non-invasive body contouring products, such as ZERONA, have become in the last few years.”
The FDA granted market clearance of Zerona for the safe and effective circumferential reduction of fat. Patients have lost an average of 4.1 inches from their waists, hips and thighs in two weeks with Zerona treatments. This average exceeds the 3.5 inches reported through the double-blind, randomized, multi-site clinical trials, submitted to the FDA. ZERONA provides patients the ability to transform their bodies without surgery, pain, bruising or swelling.
SBMI is dedicated to bringing clinically proven, innovative health and wellness products that are safe and effective to market. SBMI is the exclusive North American distributor of ZERONA, the only clinically proven, non-invasive body contouring device on the market, as well as the Erchonia EML, the only laser device FDA approved for pain during liposuction and breast surgery. For more information, visit http://www.sbmi.com.
Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years Erchonia has been conducting research & development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven to be safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit http://www.erchonia.com.